Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CIPLA vs ZYDUS LIFESCIENCES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CIPLA ZYDUS LIFESCIENCES CIPLA/
ZYDUS LIFESCIENCES
 
P/E (TTM) x 31.2 22.7 137.6% View Chart
P/BV x 4.0 2.8 142.9% View Chart
Dividend Yield % 0.5 0.5 91.2%  

Financials

 CIPLA   ZYDUS LIFESCIENCES
EQUITY SHARE DATA
    CIPLA
Mar-22
ZYDUS LIFESCIENCES
Mar-22
CIPLA/
ZYDUS LIFESCIENCES
5-Yr Chart
Click to enlarge
High Rs1,083674 160.8%   
Low Rs806331 243.6%   
Sales per share (Unadj.) Rs269.7149.1 180.9%  
Earnings per share (Unadj.) Rs31.722.7 139.6%  
Cash flow per share (Unadj.) Rs44.829.7 150.8%  
Dividends per share (Unadj.) Rs5.002.50 200.0%  
Avg Dividend yield %0.50.5 106.4%  
Book value per share (Unadj.) Rs257.8166.1 155.2%  
Shares outstanding (eoy) m806.811,023.74 78.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.53.4 104.0%   
Avg P/E ratio x29.822.1 134.7%  
P/CF ratio (eoy) x21.116.9 124.7%  
Price / Book Value ratio x3.73.0 121.1%  
Dividend payout %15.811.0 143.3%   
Avg Mkt Cap Rs m762,177514,277 148.2%   
No. of employees `000NANA-   
Total wages/salary Rs m35,29921,777 162.1%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m217,633152,652 142.6%  
Other income Rs m3,2172,354 136.7%   
Total revenues Rs m220,851155,006 142.5%   
Gross profit Rs m43,29834,427 125.8%  
Depreciation Rs m10,5207,130 147.5%   
Interest Rs m1,0641,270 83.7%   
Profit before tax Rs m34,93328,381 123.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m9,3385,117 182.5%   
Profit after tax Rs m25,59523,264 110.0%  
Gross profit margin %19.922.6 88.2%  
Effective tax rate %26.718.0 148.3%   
Net profit margin %11.815.2 77.2%  
BALANCE SHEET DATA
Current assets Rs m147,108122,614 120.0%   
Current liabilities Rs m49,12978,394 62.7%   
Net working cap to sales %45.029.0 155.4%  
Current ratio x3.01.6 191.4%  
Inventory Days Days6293 66.4%  
Debtors Days Days680 7.2%  
Net fixed assets Rs m119,248144,382 82.6%   
Share capital Rs m1,6141,024 157.6%   
"Free" reserves Rs m206,364168,972 122.1%   
Net worth Rs m207,977169,996 122.3%   
Long term debt Rs m4,1623,621 115.0%   
Total assets Rs m266,523266,996 99.8%  
Interest coverage x33.823.3 145.0%   
Debt to equity ratio x00 94.0%  
Sales to assets ratio x0.80.6 142.8%   
Return on assets %10.09.2 108.9%  
Return on equity %12.313.7 89.9%  
Return on capital %17.017.1 99.4%  
Exports to sales %26.20-   
Imports to sales %8.214.3 57.1%   
Exports (fob) Rs m57,094NA-   
Imports (cif) Rs m17,80321,869 81.4%   
Fx inflow Rs m60,18063,065 95.4%   
Fx outflow Rs m17,80321,869 81.4%   
Net fx Rs m42,37641,196 102.9%   
CASH FLOW
From Operations Rs m33,25921,041 158.1%  
From Investments Rs m-18,71911,544 -162.2%  
From Financial Activity Rs m-15,998-8,683 184.2%  
Net Cashflow Rs m-1,32323,729 -5.6%  

Share Holding

Indian Promoters % 13.5 75.0 18.0%  
Foreign collaborators % 20.1 0.0 -  
Indian inst/Mut Fund % 49.5 16.2 305.2%  
FIIs % 28.4 2.5 1,130.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 66.4 25.0 265.3%  
Shareholders   404,182 370,396 109.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CIPLA With:   SUN PHARMA    DR. REDDYS LAB    LUPIN    AUROBINDO PHARMA    LAURUS LABS     


More on Cipla vs Cadila Healthcare

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Cipla vs Cadila Healthcare Share Price Performance

Period Cipla Cadila Healthcare S&P BSE HEALTHCARE
1-Day 0.77% -1.10% 1.20%
1-Month -4.41% 6.98% -3.18%
1-Year 9.56% 18.32% -7.59%
3-Year CAGR 32.69% 19.36% 16.43%
5-Year CAGR 11.11% 3.22% 9.40%

* Compound Annual Growth Rate

Here are more details on the Cipla share price and the Cadila Healthcare share price.

Moving on to shareholding structures...

The promoters of Cipla hold a 33.6% stake in the company. In case of Cadila Healthcare the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Cipla and the shareholding pattern of Cadila Healthcare.

Finally, a word on dividends...

In the most recent financial year, Cipla paid a dividend of Rs 5.0 per share. This amounted to a Dividend Payout ratio of 15.8%.

Cadila Healthcare paid Rs 2.5, and its dividend payout ratio stood at 11.0%.

You may visit here to review the dividend history of Cipla, and the dividend history of Cadila Healthcare.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Ends 378 Points Higher | Nifty Ends Above 17,850 | Paytm & Adani Enterprises Rally 15% Sensex Today Ends 378 Points Higher | Nifty Ends Above 17,850 | Paytm & Adani Enterprises Rally 15%(Closing)

After opening the day on a positive note, Indian share markets continued their momentum as the session progressed and ended higher.